SA
MRNA icon

Scarborough Advisors’s Moderna MRNA Stock Holding History

Scarborough Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-63
Closed -$3.2K – 471
2026
Q1 		$3.2K Buy
63
+50
+385% +$2.33K ﹤0.01% 559
2025
Q4 		$383 Sell
13
-1
-7% -$27 ﹤0.01% 413
2025
Q3 		$362 Hold
14
– – ﹤0.01% 415
2025
Q2 		$386 Buy
+14
New +$369 ﹤0.01% 402
2024
Q3 		– Sell
-39
Closed -$4.63K – 321
2024
Q2 		$4.63K Buy
39
+2
+5% +$253 ﹤0.01% 268
2024
Q1 		$3.94K Hold
37
– – ﹤0.01% 271
2023
Q4 		$3.68K Buy
+37
New +$3.11K ﹤0.01% 513

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Scarborough Advisors's MRNA Position: Q2 2026 in Review

Scarborough Advisors sold out of Moderna (MRNA) in Q2 2026, closing a stake of 63 shares — an estimated $3.2K sold.

Scarborough Advisors first reported a position in MRNA in Q4 2023 and held it in 7 quarters. The position peaked at $4.63K in Q2 2024. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Scarborough Advisors reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Scarborough Advisors sold 63 Moderna shares in Q2 2026, an estimated $3.2K.
  • Scarborough Advisors first reported a position in Moderna in Q4 2023 and held it in 7 quarters.
  • Scarborough Advisors's Moderna position peaked at $4.63K in Q2 2024.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.